Overview

Assessment of Mucosal Activity to Improve the Prognosis of Patients With Crohn's Disease Treated With Immunosuppressants

Status:
Terminated
Trial end date:
2014-03-01
Target enrollment:
Participant gender:
Summary
This study will test that individualized treatment in patients with Crohn's Disease in remission or mild clinical activity under immunosuppressants may improve prognosis, rather than just treating flares.
Phase:
Phase 3
Details
Lead Sponsor:
Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa
Collaborators:
Abbott
TFS Trial Form Support
Treatments:
Adalimumab
Immunosuppressive Agents